Status:
COMPLETED
Effects of Terlipressin on Management of Potential Organ Donors
Lead Sponsor:
First Affiliated Hospital, Sun Yat-Sen University
Conditions:
Organ Donors
Eligibility:
All Genders
18-60 years
Brief Summary
During brain death, many significant systemic changes take place and among these, the most notable is hemodynamic instability. In the pathogenesis of brain death, after the hypertensive phase of the ...
Detailed Description
Thermodilution cardiac output was measured in triplicate. Hemodynamic parameters were calculated according to standard formulas.Oxygen delivery index (IDO2) was calculated as arterial oxygen content m...
Eligibility Criteria
Inclusion
- Age 10-60 years old, gender is not limited, accord with brain death standard patient.
- Complete ethical procedures, have entered the donation procedure and successful donation.
- 3 oliguria or high creatinine.
Exclusion
- Patients with uremia.
- Patients with diabetes.
- There is known to be an allergy to trelin.
- Previous patients with coronary heart disease.
- Active digestive tract hemorrhage, liver dysfunction (Child C), severe 6.coagulation dysfunction, and cannot be corrected, or other specific contraindication.
- Active HIV infection or HIV, mental disorder, etc.
Key Trial Info
Start Date :
January 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 12 2018
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT03477461
Start Date
January 1 2015
End Date
March 12 2018
Last Update
March 26 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.